Search | Proceedings | Concurrent Oral Session Grid | Author Index | eBook

Author Index: S

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Saada, A.
P3-11   HOW ILLNESS AFFECTS FAMILY MEMBERS: DOMAINS OF WELL-BEING AFFECTED BY “SPILLOVER”
Sabouri, A.
I-5   OPTIMAL SCREENING STRATEGIES OF PATIENTS ON THE KIDNEY TRANSPLANT WAITING LIST
Sadique, M. Z.
H-5   AN INTEGRATED APPROACH TO EVALUATING ALTERNATIVE RISK PREDICTION STRATEGIES: A CASE STUDY COMPARING ALTERNATIVE APPROACHES FOR PREVENTING INVASIVE FUNGAL DISEASE
Sage, J.
P2-25   PROVIDER PERSPECTIVES ON DECISION-MAKING IN JUVENILE IDIOPATHIC ARTHRITIS
Said, A.
P2-35   OPTIMAL COLORECTAL CANCER SCREENING TO BALANCE LIFE-YEAR SAVINGS AND COSTS
Saigal, C. S.
P3-3   TREATMENT PREFERENCES DERIVED USING ADAPTIVE BEST-WORST CONJOINT (ABC) ANALYSIS,
P3-35   IMPACT OF A NOVEL METHOD OF PATIENT PREFERENCE ELICITATION ON DECISION QUALITY IN MEN WITH PROSTATE CANCER: PILOT DATA
Sainfort, F.
P1-4   LINEAR REGRESSION METAMODELING AS A TOOL TO SUMMARIZE AND PRESENT SIMULATION MODEL OUTPUTS,
P1-53   SENSITIVITY ANALYSIS METHODS FOR DECISION MODELS: A REVIEW AND TWO NOVEL TECHNIQUES,
P3-16   WHEN AND FOR WHOM ARE BIOLOGICS COST-EFFECTIVE IN RHEUMATOID ARTHRITIS?
Saini, S.
P1-28   ON STRATEGIES TO CONTROL HEALTHCARE COSTS: INFLUENCING PATIENTS TO “SELF-RATION” BY COMMUNICATING THE SOCIAL IMPLICATIONS OF OVERUSE
Sakaguchi, F. H.
P3-31   DISCHARGE SUMMARIES FREQUENTLY FAIL TO PROVIDE MEDICAL REASONING THAT IS IMPORTANT FOR CONTINUITY OF CARE
Sakai, M.
P2-27   DEVELOPMENT AND EVALUATION OF THE “EMERGENCY MEDICAL ALLIANCE FOR TOTAL COODINATION IN HEALTHCARE (E-MATCH)” TO PROMOTE SHARED DECISION MAKING BETWEEN EMTS AND MEDICAL FACILITIES
Sales, A.
P2-30   HEALTHCARE PROVIDERS' INTENTIONS TO ENGAGE IN AN INTERPROFESSIONAL APPROACH TO SHARED DECISION MAKING IN HOME CARE PROGRAMS: A MIXED METHODS STUDY
Salomon, J. A.
L-3   COMPARING FIFTEEN APPROACHES OF ASSESSING CARDIOVASCULAR DISEASE RISK USING RECEIVER OPERATING CHARACTERISTIC (ROC) CURVE ANALYSIS,
TRA2-2   ESTIMATING THE COST-EFFECTIVENESS OF XPERT MTB/RIF: APPLYING A BAYESIAN CALIBRATION APPROACH TO A DYNAMIC TB-HIV EPIDEMIC MODEL
Samore, M.
P2-55   MODELING FOODBORNE OUTBREAKS: CHALLENGES FOR PUBLIC HEALTH INVESTIGATION
Sanchez-Tomay, N. B.
P4-49   COST EFFECTIVENESS OF STRATEGIES FOR DIAGNOSIS OF HEPATITIS C IN MEXICO
Sander, B.
K-1   THE COST-EFFECTIVENESS OF INTEGRATED CERVICAL CANCER PREVENTION STRATEGIES IN THE ONTARIO SETTING – CAN WE DO BETTER?
Sanders, G. D.
P1-40   NET EFFECT OF CURRENT PATTERNS OF ORAL CONTRACEPTIVE USE ON POTENTIALLY FATAL OUTCOMES IN THE UNITED STATES,
P1-41   USING NET BENEFITS AND ACCEPTABILITY CURVES TO QUANTIFY UNCERTAINTY ABOUT TRADEOFFS BETWEEN HARMS AND BENEFITS OF ORAL CONTRACEPTIVES
Saner, D.
P1-37   CREATION OF A GENOMIC PRESCRIBING SYSTEM FOR DELIVERY OF PHARMACOGENOMIC RESULTS AND PERSONALIZED PRESCRIPTION DECISION-MAKING
Sansom, S.
F-4   COST-EFFECTIVENESS OF MORE FREQUENT HIV SCREENING OF POPULATIONS AT RISK,
P1-15   ESTIMATING LIFETIME HIV TREATMENT COSTS IN THE UNITED STATES: EARLY VERSUS LATE ENTRY INTO CARE
Sargeant, J.
P2-29   INTERNATIONAL WORKING GROUP ON CORE COMPETENCIES FOR TRAINING HEALTH PROFESSIONALS IN SHARED DECISION MAKING HIGHLIGHTS THE HETEROGENEITY OF CURRENT PROGRAMS
Sato, M.
P3-25   COST-EFFECTIVENESS ANALYSIS OF BREAST CANCER SCREENING: DOUBLE READING VERSUS 1 + CAD READING
Savella, M.
H-2   META-ANALYSIS OF REAL-WORLD STUDIES OF INITIATING INSULIN GLARGINE VIA DISPOSABLE PEN VERSUS VIAL/SYRINGE AMONG PATIENTS WITH TYPE 2 DIABETES: APPLYING A COMMON DATA STRUCTURE TO A UNIQUE EVIDENCE SYNTHESIS PLATFORM
Saverno, K.
P3-34   VISUALIZING THE OUTCOMES OF DECISION-ANALYTIC MODELING STUDIES IN THE FRAMEWORK OF HEALTH TECHNOLOGY ASSESSMENT,
P4-45   PRELIMINARY OUTCOMES TOWARDS A RISK-BASED MICROSIMULATION DECISION-ANALYTICAL MODEL BASED ON TREATMENT AND COST INPUTS FROM A REAL WORLD COHORT OF BREAST CANCER PATIENTS
Sax, P. E.
K-5   COST-EFFECTIVENESS ANALYSIS OF UGT1A1 GENETIC TESTING TO INFORM INITIAL ANTIRETROVIRAL PRESCRIBING FOR TREATMENT OF HIV IN THE US
Scalia-Tomba, G.
P2-14   HUMAN PAPILLOMAVIRUS GENOTYPE PREVALENCE IN ITALY AFTER NATIONWIDE VACCINATION: A DYNAMIC TRANSMISSION MODEL
Scardino, P. T.
P3-37   THE ECONOMIC IMPACT OF ROBOTIC AND OPEN RADICAL PROSTATECTOMY ON PATIENTS AND THEIR FAMILIES
Schackman, B. R.
K-5   COST-EFFECTIVENESS ANALYSIS OF UGT1A1 GENETIC TESTING TO INFORM INITIAL ANTIRETROVIRAL PRESCRIBING FOR TREATMENT OF HIV IN THE US,
P4-16   THE IMPACT OF CURRENT ILLICIT DRUG USE ON QUALITY OF LIFE IN HIV INFECTED AND AT RISK WOMEN: IMPLICATIONS FOR COMBINED HEALTH UTILITIES
Schauer, D. P.
P1-1   COST-EFFECTIVENESS OF FOUR DIFFERENT STRATEGIES FOR EVALUATION OF FEVER IN INFANTS LESS THAN 60 DAYS OF AGE
Schenkel, B.
P3-29   PATIENT-REPORTED SATISFACTION ON USTEKINUMAB TREATMENT COMPARED WITH PRIOR BIOLOGIC THERAPY,
P4-26   UTILIZATION OF USTEKINUMAB IN BIOLOGIC-EXPERIENCED AND BIOLOGIC-NAïVE PSORIASIS PATIENTS
Scherer, L.
J-6   ANXIETY AND ACTION BIAS AS PREDICTORS OF PROSTATE CANCER TREATMENT PREFERENCES AND TREATMENT DECISIONS,
P1-28   ON STRATEGIES TO CONTROL HEALTHCARE COSTS: INFLUENCING PATIENTS TO “SELF-RATION” BY COMMUNICATING THE SOCIAL IMPLICATIONS OF OVERUSE,
TRA1-2   WHAT'S IN A NAME? THE INFLUENCE OF A DISEASE LABEL ON A PARENT'S DECISION TO MEDICATE A FUSSY BABY
Scherer, L. D.
G-1   BLOCKS, OVALS, OR PEOPLE: DOES ICON TYPE IN PICTOGRAPHS INFLUENCE THE CORRELATION BETWEEN PERCEIVED AND ACTUAL RISK?,
J-2   HOLD MY HAND: EXPLICITLY SHOWING TRADEOFFS AND FIT BETWEEN VALUES AND OPTIONS HELPS PEOPLE MAKE CHOICES CONCORDANT WITH THEIR STATED VALUES
Schink, J.
P4-27   INTEGRATING THE PATIENT-REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM (PROMIS) SYMPTOM ASSESSMENT INTO ROUTINE CANCER CARE
Schirmer, P.
P4-42   ARE ORGANIC FOODS SAFER OR HEALTHIER THAN CONVENTIONAL ALTERNATIVES? A SYSTEMATIC REVIEW
Schlender, A. B.
P2-54   CHARACTERIZATION OF PULMONARY FUNCTION DECLINE FOR SUSCEPTIBLE AND NON-SUSCEPTIBLE SMOKERS,
P4-1   AN INTEGRATED SIMULATION MODEL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Schmeichel-Mueller, C.
P3-29   PATIENT-REPORTED SATISFACTION ON USTEKINUMAB TREATMENT COMPARED WITH PRIOR BIOLOGIC THERAPY
Schmitz, S.
P2-22   A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS: EFFECT ON KNOWLEDGE, PREPAREDNESS FOR DECISION-MAKING, SELF-EFFICACY, AND WILLINGNESS TO PARTICIPATE,
P3-5   REACTIONS TO A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS AND ITS EFFECT ON ATTITUDES TOWARDS PARTICIPATION
Schmutz, E. Jr.
P2-53   META-ANALYSIS OF STUDIES COMPARING ADJUVANT CHEMOTHERAPY WITH SURGERY ALONE IN NON-SMALL CELL LUNG CANCER
Schneider, B. P.
P3-41   DOES UNBLINDING OF TREATMENT ASSIGNMENT IMPACT PARTICIPANT PERCEPTIONS IN CLINICAL TRIALS?
Scholl, I.
P3-1   THE IMPLEMENTATION OF PATIENT DECISION SUPPORT INTERVENTIONS INTO ROUTINE CLINICAL PRACTICE: A SYSTEMATIC REVIEW
Schousboe, J.
K-3   IS REFUSAL TO TAKE FRACTURE PREVENTION MEDICATION SOMETIMES A RATIONAL DECISION? AN EXPLORATORY ANALYSIS THROUGH THE LENS OF COST-EFFECTIVENESS,
P3-16   WHEN AND FOR WHOM ARE BIOLOGICS COST-EFFECTIVE IN RHEUMATOID ARTHRITIS?
Schubart, J. R.
P4-24   RELIABILITY OF AN ONLINE DECISION AID FOR ADVANCE CARE PLANNING: AN APPLICATION OF GENERALIZABILITY THEORY
Schuetz, C. A.
P2-45   COMPARING THE EFFECTIVENESS OF ATORVASTATIN AND ROSUVASTATIN FOR MANAGING ELEVATED CHOLESTEROL IN CLINICAL PRACTICE SETTINGS: A SIMULATED STUDY
Schulman, D.
P4-34   DEVELOPING VIRTUAL PATIENT ADVOCATE TECHNOLOGY FOR SHARED DECISION MAKING
Schulman, K. A.
K-4   MULTIFACTORIAL DECISION MAKING FOR CHEMOTHRAPY IN EARLY-STAGE BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS OF ONCOTYPE DX
Schumacher, J. R.
P1-30   LONG-TERM BREAST CANCER SURVIVORS' PERCEPTIONS OF CANCER RISK: A MENTAL MODELS STUDY
Schwartz, A.
B-5   PSYCHOMETRIC PROPERTIES OF A NEW MEDICAL RISK SUBSCALE FOR DOSPERT
Schwartz, J. S.
P2-43   PHYSICIAN PREFERENCES FOR THE CONDUCT AND PRESENTATION OF COMPARATIVE EFFECTIVENESS RESEARCH
Scilla, R.
P2-34   LONG DISTANCE TRIAGE: ASSESSING PATIENT RISK FOR INTER-HOSPITAL TRANSFER PATIENTS
Scotch, M.
SYM2-1   BIOMEDICAL INFORMATICS TO ENHANCE CLINICAL AND PUBLIC HEALTH DECISION MAKING,
SYM2-2   PUBLIC HEALTH INFORMATICS TO SUPPORT PUBLIC HEALTH DECISION MAKING
Scott, P. A.
P4-37   ECONOMIC BENEFIT OF AN EDUCATIONAL INTERVENTION TO IMPROVE TPA USE IN COMMUNITY HOSPITALS
Seekins, D.
P1-39   PATTERNS AND CORRELATES OF LINKAGE TO APPROPRIATE HIV CARE FOLLOWING HIV DIAGNOSIS IN THE UNITED STATES MEDICAID POPULATION
Segelman, M.
P3-44   PT VS TKA: WEIGHING THE PROS AND CONS
Selig, J.
P4-56   PREDICTORS OF PROSTATE CANCER SCREENING: A MULTILEVEL MODELING APPROACH
Seoud, M.
E-6   COST-EFFECTIVENESS OF INCREASING CERVICAL CANCER SCREENING COVERAGE AND EFFICIENCY IN LEBANON
Sepucha, K. R.
P1-22   INFORMATION-SEEKING BEHAVIOR AND DECISION MAKING IN PATIENTS UNDERGOING ELECTIVE CARDIAC PROCEDURES,
P1-25   RESULTS FROM A DECISION MAKING SURVEY OF LATINA BREAST CANCER PATIENTS,
P2-20   MEASURING PREFERENCES AROUND MODES OF DEATH, THE CASE OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS,
P3-41   DOES UNBLINDING OF TREATMENT ASSIGNMENT IMPACT PARTICIPANT PERCEPTIONS IN CLINICAL TRIALS?
Sereika, S. M.
P1-16   WHO INITIATES CANCER SYMPTOM MANAGEMENT DISCUSSIONS? FACTORS ASSOCIATED WITH PATIENT VS. CLINICIAN INITIATION IN WOMEN WITH OVARIAN CANCER
Sergel, M.
P4-50   USING DISASTER PREPAREDNESS PRINCIPLES TO IMPROVE MEDICAL EDUCATION AND HEALTH CARE PERFORMANCE OUTCOMES
Shaffer, B. L.
P3-48   TIMING DELIVERY OF PLACENTA ACCRETA: A DECISION ANALYSIS
Shaffer, J. A.
P1-13   COST-EFFECTIVENESS OF ENHANCED DEPRESSION CARE FOR PATIENTS WITH ACUTE CORONARY SYNDROME AND DEPRESSIVE SYMPTOMS: RESULTS OF THE COPES RANDOMIZED CONTROLLED TRIAL
Shaffer, V. A.
P4-17   THE EFFECT OF NARRATIVE FORMAT ON INFORMATION SEARCH USING A WEB-BASED BREAST CANCER DECISION AID
Shah, G. K.
P3-28   A COMPARISON OF THE WILLINGNESS TO PAY FOR THE PREVENTION OF VISUAL IMPAIRMENT BETWEEN A COMMUNITY BASED SAMPLE AND PEOPLE WITH VISUAL IMPAIRMENT
Shah, K. K.
AWD2-1   EUROPEAN 2012 MEETING AWARD FOR OUTSTANDING PAPER BY A YOUNG INVESTIGATOR
Shah, N. D.
P1-47   OPTIMIZATION OF HYPERGLYCEMIA TREATMENT INTENSIFICATION FOR PATIENTS WITH TYPE 2 DIABETES
Shah, N. R.
KEY-1   BUILDING A HEALTHCARE ECOSYSTEM
Shalaby, A. M.
P1-49   BAYESIAN CONTACT TRACING FOR COMMUNICABLE RESPIRATORY DISEASE
Shamsi, N.
P4-51   CAN PLOTTING CLINICAL TREATMENT RESPONSE RATES AND CALCULATING DISEASE SLOPES OVER TIME IMPROVE MEDICAL DECISION MAKING?
Shank, T.
P3-30   ASSESSING HEALTHCARE PROVIDER SATISFACTION OF SERVICES PROVIDED BY THE ARIZONA REGIONAL EXTENSION CENTER (REC): A CROSS-SECTIONAL SURVEY
Sharma, M.
E-6   COST-EFFECTIVENESS OF INCREASING CERVICAL CANCER SCREENING COVERAGE AND EFFICIENCY IN LEBANON,
P2-4   DIRECT COSTS OF HEAD AND NECK CANCER IN THE UNITED STATES: ESTIMATES FROM THE 2005-2009 MEDICAL EXPENDITURE PANEL SURVEY (MEPS)
Shaw, J. G.
P1-2   COST-EFFECTIVENESS OF ROUTINE USE OF MAGNESIUM SULFATE FOR SEIZURE PROPHYLAXIS IN MILD PREECLAMPSIA
Shaz, B.
L-6   COST-EFFECTIVENESS OF BLOOD DONOR SCREENING FOR BABESIOSIS IN ENDEMIC REGIONS
Shechter, S. M.
I-2   OPTIMIZING GUIDELINES FOR TIMING OF ARTERIOVENOUS FISTULA CREATION IN CHRONIC KIDNEY DISEASE,
I-5   OPTIMAL SCREENING STRATEGIES OF PATIENTS ON THE KIDNEY TRANSPLANT WAITING LIST
Shechter, S. M.
INF-1   INFORMS/SMDM APPLICATIONS JOINT CLUSTER
Sherwood, P. R.
P1-16   WHO INITIATES CANCER SYMPTOM MANAGEMENT DISCUSSIONS? FACTORS ASSOCIATED WITH PATIENT VS. CLINICIAN INITIATION IN WOMEN WITH OVARIAN CANCER
Shiffman, R. N.
SYM1-4   SUMMARY AND DISCUSSION / QUESTIONS
Shirani, M.
P4-51   CAN PLOTTING CLINICAL TREATMENT RESPONSE RATES AND CALCULATING DISEASE SLOPES OVER TIME IMPROVE MEDICAL DECISION MAKING?
Shluzas, L. A.
B-2   EXAMINING PARAMETERS THAT IMPACT INCREMENTAL COST-EFFECTIVENESS RATIOS
Shokar, N. S.
P1-54   NON-ADDITIVE MEASURES IN MEDICAL DECISION MAKING
Siebert, U.
P3-34   VISUALIZING THE OUTCOMES OF DECISION-ANALYTIC MODELING STUDIES IN THE FRAMEWORK OF HEALTH TECHNOLOGY ASSESSMENT,
P4-45   PRELIMINARY OUTCOMES TOWARDS A RISK-BASED MICROSIMULATION DECISION-ANALYTICAL MODEL BASED ON TREATMENT AND COST INPUTS FROM A REAL WORLD COHORT OF BREAST CANCER PATIENTS
Silka, P.
P3-10   ELECTRONIC REPORTING TO ASSESS AND IMPROVE VENOUS THROMBOEMBOLISM PROPHYLAXIS
Silva, K. N.
P2-34   LONG DISTANCE TRIAGE: ASSESSING PATIENT RISK FOR INTER-HOSPITAL TRANSFER PATIENTS
Simon, M. S.
L-6   COST-EFFECTIVENESS OF BLOOD DONOR SCREENING FOR BABESIOSIS IN ENDEMIC REGIONS
Simon, M.
P3-38   INTERSECTORAL HEALTH ACTION IN TANZANIA – DETERMINANTS AND POLICY IMPLICATIONS
Singer, M. E.
P2-5   THE COST-EFFECTIVENESS OF SULINDAC-DIFLUOROMETHYLORNITHINE FOR THE PREVENTION OF COLORECTAL CANCER
Sitter, H.
P2-53   META-ANALYSIS OF STUDIES COMPARING ADJUVANT CHEMOTHERAPY WITH SURGERY ALONE IN NON-SMALL CELL LUNG CANCER
Skandari, M. R.
I-2   OPTIMIZING GUIDELINES FOR TIMING OF ARTERIOVENOUS FISTULA CREATION IN CHRONIC KIDNEY DISEASE
Skiest, D.
H-3   A PNEUMONIA MORTALITY MODEL BASED ON HIGHLY DETAILED ADMINISTRATIVE DATA
Sledge, G. W. Jr.
P3-41   DOES UNBLINDING OF TREATMENT ASSIGNMENT IMPACT PARTICIPANT PERCEPTIONS IN CLINICAL TRIALS?
Smeets, H. J.
P3-17   DO STARS HELP PATIENTS TO CHOOSE A HOSPITAL FOR SURGERY? A HOSPITAL CHOICE EXPERIMENT
Smith, A. B.
P2-7   SURVEILLANCE GUIDELINES FOR LOW GRADE NON-INVASIVE BLADDER CANCER: A COST COMPARISON
Smith, B.
P1-8   THE VALUE OF INFORMATION OF ADDITIONAL RESEARCH REGARDING BIRTH-COHORT SCREENING FOR HEPATITIS C
Smith, K. J.
F-1   COST-EFFECTIVENESS OF PNEUMOCOCCAL CONJUGATE VACCINATION IN THE IMMUNOCOMPROMISED
Smith, S.
P1-47   OPTIMIZATION OF HYPERGLYCEMIA TREATMENT INTENSIFICATION FOR PATIENTS WITH TYPE 2 DIABETES
Smith-Spangler, C. M.
P4-42   ARE ORGANIC FOODS SAFER OR HEALTHIER THAN CONVENTIONAL ALTERNATIVES? A SYSTEMATIC REVIEW,
P4-43   TRUST AND COMPARATIVE EFFECTIVENESS RESEARCH: METHODS, POLICIES, AND FUTURE DIRECTIONS FOR REPRODUCIBLE RESEARCH
Smolderen, K.
P1-22   INFORMATION-SEEKING BEHAVIOR AND DECISION MAKING IN PATIENTS UNDERGOING ELECTIVE CARDIAC PROCEDURES
Soeteman, D. I.
P2-44   MODELING THE EFFECTIVENESS OF INITIAL MANAGEMENT STRATEGIES FOR DUCTAL CARCINOMA IN SITU
Solnik, E.
TRA1-5   AN INFUENZA VACCINATION POLICY BASED ON A PREVIOUS YEAR'S ILLNESS
Soneji, S.
P2-42   IMPROVING POPULATION HEALTH THROUGH OPTIMIZING COLON CANCER SCREENING
Song, J.
H-6   BARIATRIC SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS, 2003-PRESENT
Sonnad, S. S.
P2-43   PHYSICIAN PREFERENCES FOR THE CONDUCT AND PRESENTATION OF COMPARATIVE EFFECTIVENESS RESEARCH
Soulsby, M.
P2-12   DEVELOPMENT AND EVALUATION OF AN ANALYTICAL POLICY TOOL
Sozener, C. B.
P4-37   ECONOMIC BENEFIT OF AN EDUCATIONAL INTERVENTION TO IMPROVE TPA USE IN COMMUNITY HOSPITALS
Speakman, J.
SYM2-4   HARNESSING CLINICAL RESEARCH INFORMATICS TO SUPPORT CLINICAL DECISION MAKING
Spitz, J.
P1-37   CREATION OF A GENOMIC PRESCRIBING SYSTEM FOR DELIVERY OF PHARMACOGENOMIC RESULTS AND PERSONALIZED PRESCRIPTION DECISION-MAKING
Sroczynski, G.
P3-34   VISUALIZING THE OUTCOMES OF DECISION-ANALYTIC MODELING STUDIES IN THE FRAMEWORK OF HEALTH TECHNOLOGY ASSESSMENT
Stableford, S.
P2-22   A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS: EFFECT ON KNOWLEDGE, PREPAREDNESS FOR DECISION-MAKING, SELF-EFFICACY, AND WILLINGNESS TO PARTICIPATE,
P3-5   REACTIONS TO A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS AND ITS EFFECT ON ATTITUDES TOWARDS PARTICIPATION
Stacey, D.
P2-26   DEVELOPMENT AND USABILITY TESTING OF ANSWER: A WEB-BASED METHOTREXATE DECISION AID FOR PATIENTS WITH RHEUMATOID ARTHRITIS,
P2-29   INTERNATIONAL WORKING GROUP ON CORE COMPETENCIES FOR TRAINING HEALTH PROFESSIONALS IN SHARED DECISION MAKING HIGHLIGHTS THE HETEROGENEITY OF CURRENT PROGRAMS,
P2-30   HEALTHCARE PROVIDERS' INTENTIONS TO ENGAGE IN AN INTERPROFESSIONAL APPROACH TO SHARED DECISION MAKING IN HOME CARE PROGRAMS: A MIXED METHODS STUDY
Stahl, J.
P1-59   GROWING WISER AND WIDER: THE COST-BENEFIT OF UNIVERSAL DESIGN IN MITIGATING LIMITED MOBILITY IN URGENT CARE SETTING,
P4-9   REAL-TIME LOCATION SYSTEMS, NORMATIVE MESSAGING AND CHANGING CLINICIAN BEHAVIOR
Stahl, J.
P1-60   COST-EFFICIENT DESIGN OF EPIDEMIOLOGICAL STUDIES USING DISCRETE EVENT SIMULATION MODEL – EPISOL STUDY SIMULATOR 1.0,
P3-8   FACE-TIME VERSUS TEST ORDERING: IS THERE A TRADE-OFF?,
P3-9   OPTIMIZING OUTPATIENT RESIDENCY TRAINING: BALANCING CLINICAL EXPERIENCE WITH ACCESS TO CARE,
P3-49   USING RFID-BASED REAL-TIME LOCATION SYSTEMS TO DESCRIBE AND UNDERSTAND SOCIAL NETWORKS IN THE OUTPATIENT SETTING,
P3-50   EXPLORING USER RESISTANCE AND TECHNOLOGY ADOPTION FACTORS IN HEALTHCARE,
P4-10   IN-GROUP/OUT-GROUP – DOES IT MAKE A DIFFERENCE? GENDER, ETHNICITY, RACE AND FACE-TIME
Stalmeier, P. F. M.
P1-24   PATIENT'S DESIRE FOR INFORMATION: A STUDY IN THE ADVANCED CANCER SETTING,
P3-42   ONCOLOGISTS' AND NURSES' VIEWS ON THE IMPLEMENTATION OF DECISION AIDS ON SECOND-LINE PALLIATIVE CHEMOTHERAPY IN ROUTINE PRACTICE
Starren, J. B.
SYM1-3   INTEGRATION OF GENOMICS AND CLINICAL DECISION SUPPORT FOR AGING PATIENTS
Stave, C.
P4-42   ARE ORGANIC FOODS SAFER OR HEALTHIER THAN CONVENTIONAL ALTERNATIVES? A SYSTEMATIC REVIEW
Stavem, K.
J-5   WHAT FACTORS EXPLAIN WILLINGNESS TO TRADE TIME IN THE TIME TRADE-OFF EXERCISES, AND WHAT FACTORS ARE IMPORTANT?,
P2-41   POSTAL OR WEB-BASED? POPULATION REPRESENTATIVENESS IN HEALTH SURVEY SETTINGS
Stein, J. D.
E-2   COST EFFECTIVENESS OF DIFFERENT INTERVENTIONS FOR TREATING PATIENTS WITH NEWLY-DIAGNOSED DIABETIC MACULAR EDEMA
Stenehjem, D.
P2-3   ABSTRACT WITHDRAWN - ECONOMIC EVALUATION OF 21-GENE ASSAY FOR EARLY STAGE BREAST CANCER PATIENTS FROM A PERSPECTIVE OF CHINESE HEALTH CARE SYSTEM,
P4-45   PRELIMINARY OUTCOMES TOWARDS A RISK-BASED MICROSIMULATION DECISION-ANALYTICAL MODEL BASED ON TREATMENT AND COST INPUTS FROM A REAL WORLD COHORT OF BREAST CANCER PATIENTS
Steuten, L.
K-6   COST-EFFECTIVENESS OF METAL-ON-METAL HIP RESURFACING COMPARED TO CONVENTIONAL TOTAL HIP ARTHROPLASTY
Steyerberg, E. W.
P1-32   MODELING THE ADDED PREDICTIVE VALUE OF A NOVEL CARDIOVASCULAR RISK MARKER WITH A SIMPLE MARKOV MODEL,
P2-51   ITERATIVE CALIBRATION OF MONTE-CARLO MARKOV MODELS USED FOR EVALUATING THE IMPACT OF UPDATING TRADITIONAL CARDIOVASCULAR RISK PREDICTIONS WITH NOVEL RISK MARKERS,
P4-36   MEN'S PREFERENCES FOR PROSTATE CANCER SCREENING: A DISCRETE CHOICE EXPERIMENT
Stickelman, V.
P4-40   DO VALID FILM DECISION-AIDS INFORM PARENTS ON POTENTIAL OUTCOMES OF EXTREME PREMATURITY WITHOUT CREATING STRESS?
Stiggelbout, A. M.
D-1   TESTING THE ADDED VALUE OF DECISION AID COMPONENTS TO FACILITATE PATIENTS INFORMED DECISION MAKING ABOUT DIALYSIS TREATMENT OPTIONS,
PRES-1   SMDM: IN QUEST OF QUALITY,
P1-23   SUPPORTING PATIENT DECISION-MAKING FOR SURGERY VERSUS PROLONGED CONSERVATIVE TREATMENT FOR HERNIATED DISK: EVALUATION OF ENRICHED VIDEO AND TEXTUAL WEB-BASED PATIENT DECISION AIDS IN A MULTI-CENTER RANDOMIZED TRIAL,
P4-20   BARRIERS AND FACILITATORS TO IMPLEMENT SHARED DECISION MAKING IN TREATMENT OF SCIATICA PATIENTS,
P4-33   EXPLICIT ATTITUDES SEEM MORE DECISIVE FOR INTENTIONS ABOUT CERVICAL CANCER SCREENING THAN IMPLICIT ATTITUDES
Stoll, C. R. T.
H-6   BARIATRIC SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS, 2003-PRESENT
Stout, N. K.
P2-44   MODELING THE EFFECTIVENESS OF INITIAL MANAGEMENT STRATEGIES FOR DUCTAL CARCINOMA IN SITU
Stout, N. K.
P2-2   ECONOMIC EVALUATION OF HLA-B*1502 GENE SCREENING FOR THE PREVENTION OF CARBAMAZEPINE-INDUCED TOXIC EFFECTS IN TAIWAN
Straus, H.
P4-50   USING DISASTER PREPAREDNESS PRINCIPLES TO IMPROVE MEDICAL EDUCATION AND HEALTH CARE PERFORMANCE OUTCOMES
Strohl, K. P.
P1-29   PHYSICIAN OVERUTILIZATION OF SLEEP STUDIES IN PREDICTING PATIENT IMPROVEMENT USING CPAP
Strong, M.
P3-31   DISCHARGE SUMMARIES FREQUENTLY FAIL TO PROVIDE MEDICAL REASONING THAT IS IMPORTANT FOR CONTINUITY OF CARE
Studts, J. L.
J-1   BRIEF EDUCATION AND COMPLETING A CONJOINT VALUATION SURVEY REDUCE DECISIONAL CONFLICT REGARDING LUNG CANCER SCREENING AMONG INDIVIDUALS AT-RISK FOR LUNG CANCER,
P1-20   WHAT ATTRIBUTES OF A LUNG CANCER SCREENING TEST AFFECT INTEREST IN BEING SCREENED?,
P2-22   A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS: EFFECT ON KNOWLEDGE, PREPAREDNESS FOR DECISION-MAKING, SELF-EFFICACY, AND WILLINGNESS TO PARTICIPATE,
P3-5   REACTIONS TO A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS AND ITS EFFECT ON ATTITUDES TOWARDS PARTICIPATION,
P4-5   INDIVIDUAL CHARACTERISTICS ASSOCIATED WITH DIFFERENCES IN DESIRE FOR LUNG CANCER SCREENING
Suen, S. C.
L-2   DYNAMIC TRANSMISSION MICROSIMULATION OF TUBERCULOSIS IN INDIA TO ASSESS THE FUTURE IMPACT OF TREATMENT PROGRAMS
Suh, S.
P4-40   DO VALID FILM DECISION-AIDS INFORM PARENTS ON POTENTIAL OUTCOMES OF EXTREME PREMATURITY WITHOUT CREATING STRESS?
Summers, B.
D-1   TESTING THE ADDED VALUE OF DECISION AID COMPONENTS TO FACILITATE PATIENTS INFORMED DECISION MAKING ABOUT DIALYSIS TREATMENT OPTIONS
Sun, Y.
P2-39   PROGNOSTIC MODEL FOR PREDICTING PATIENTS AT HIGH RISK OF EMERGENT HOSPITAL READMISSION WITHIN 30 DAYS AFTER DISCHARGE USING ADMINISTRATIVE DATA
Sundaram, V.
P4-42   ARE ORGANIC FOODS SAFER OR HEALTHIER THAN CONVENTIONAL ALTERNATIVES? A SYSTEMATIC REVIEW
Suter, L. G.
P2-24   PATIENTS' PREFERENCES TO INFORM DRUG DEVELOPMENT,
P3-15   WHEN DO PHYSICIANS RECOMMEND JOINT REPLACEMENT FOR PATIENTS WITH MODERATE DISEASE?
Swaby, R. F.
P3-41   DOES UNBLINDING OF TREATMENT ASSIGNMENT IMPACT PARTICIPANT PERCEPTIONS IN CLINICAL TRIALS?
Swartz, M.
P1-31   IDENTIFYING FACTORS ASSOCIATED WITH STATE PSYCHIATRIC HOSPITAL USE TO INFORM ADMISSION, REFERRAL, AND POLICY DECISION-MAKING
Sycara, K.
L-4   THE WELFARE CONSEQUENCES OF THE DONOR PRIORITY RULE
Symeonidis, I.
P4-44   EMPOWERING PATIENT DECISION MAKING AND HEALTH MANAGEMENT: EVALUATING INDIVIDUAL PREFERENCES AND WILLINGNESS TO ADOP HEALTH INFORMATION TECHNOLOGIES
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z